Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
---|---|---|---|---|
![]() | Butyl (3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-isobutylthiophen-2-yl)sulfonylcarbamate REF: IN-DA00DM1RCAS: 477775-14-7 | 98% | Prezzo su richiesta | Gio 27 Mar 25 |
![]() | AT2 receptor agonist C21 REF: 3D-CUA77514CAS: 477775-14-7 | Min. 95% | 331,00 €~1.071,00 € | Gio 08 Mag 25 |
![]() | Buloxibutid REF: TM-T14337CAS: 477775-14-7 | 97.68% - 98.58% | 49,00 €~1.501,00 € | Gio 15 Mag 25 |

Butyl (3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-isobutylthiophen-2-yl)sulfonylcarbamate
CAS:477775-14-7
Formula:
C23H29N3O4S2
Purezza:
98%
Colore e forma:
Solid
Peso molecolare:
475.6240599999998
Ref: IN-DA00DM1R
1mg | 76,00 € | ||
5mg | 126,00 € | ||
10mg | 193,00 € | ||
25mg | 270,00 € | ||
50mg | 494,00 € |
Consegna stimata in Stati Uniti, il Giovedì 27 Marzo 2025

AT2 receptor agonist C21
CAS:477775-14-7
C21 is a potent and selective agonist of the AT2 receptor. It has been shown …
Formula:
C23H29N3O4S2
Purezza:
Min. 95%
Peso molecolare:
475.6 g/mol
Ref: 3D-CUA77514
5mg | 331,00 € | ||
10mg | 373,00 € | ||
25mg | 598,00 € | ||
50mg | 759,00 € | ||
100mg | 1.071,00 € |
Consegna stimata in Stati Uniti, il Giovedì 08 Maggio 2025

Buloxibutid
CAS:477775-14-7
Buloxibutid: a novel AT2 receptor agonist, Ki=0.4 nM (AT2), 10 μM (AT1).
Formula:
C23H29N3O4S2
Purezza:
97.68% - 98.58%
Colore e forma:
Solid
Peso molecolare:
475.62
Ref: TM-T14337
1mg | 49,00 € | ||
5mg | 97,00 € | ||
10mg | 154,00 € | ||
25mg | 274,00 € | ||
50mg | 432,00 € | ||
100mg | 747,00 € | ||
500mg | 1.501,00 € | ||
1mL*10mM (DMSO) | 97,00 € |
Consegna stimata in Stati Uniti, il Giovedì 15 Maggio 2025